Evidence map›Paper›PMID 22362401›Full record

Trial reportJournal of applied physiology (Bethesda, Md. : 1985)2012

Reactive hyperemia is not responsible for stimulating muscle protein synthesis following blood flow restriction exercise.

David M Gundermann, Christopher S Fry, Jared M Dickinson, Dillon K Walker, Kyle L Timmerman, Micah J Drummond, Elena Volpi, Blake B Rasmussen

Registry-linked trialOpen access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of applied physiology (Bethesda, Md. : 1985), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00891696 (Nutritional and Contractile Regulation of Muscle Growth), which is not on this map. Cited by 40 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 3 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00891696 phase1completednot on this map

Nutritional and Contractile Regulation of Muscle Growth (Cycle 2)

TypeinterventionalSponsorThe University of Texas Medical Branch, GalvestonRan2009 to 2015Enrolled144ConditionsSarcopeniaArmsRapamycin, Amino acid supplementation, Low-intensity resistance exercise, Sodium nitroprusside, Blood flow restriction cuff
3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 3 syntheses or guidelines pooled it, 99 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Post-exercise blood flow restriction attenuates muscle hypertrophy.European journal of applied physiology · 2016
    Trial
  10. Trial
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Effects of blood flow restriction (BFR) with resistance exercise on musculoskeletal health in older adults: a narrative review.European review of aging and physical activity : official journal of the European Group for Research into Elderly and Physical Activity · 2022
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

David M GundermannThe Univ. of Texas Medical Branch, Dept. of Nutrition and Metabolism, Division of Rehabilitation Sciences, 301 Univ. Blvd., Galveston, TX 77555-1124, USA.
Christopher S Fry
Jared M Dickinson
Dillon K Walker
Kyle L Timmerman
Micah J Drummond
Elena Volpi
Blake B Rasmussen
Nutrition Sciences (Belgium) · BEThe University of Texas Medical Branch at Galveston · US

Funding

UTMB OAIC Research Education Component (REC)P30AG024832 · NIA · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI JAMES S. GOODWIN, MD, MELISSA M. MORROW · 2005 to 2026
$26.7M
UTMB Clinical and Translational Science AwardUL1TR000071 · NCATS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI BRASIER, ALLAN R. · 2012 to 2014
$14.4M
Nutritional and Contractile Regulation of Muscle GrowthR01AR049877 · NIAMS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI RASMUSSEN, BLAKE B · 2004 to 2012
$3.3M
Interdisciplinary Rehabilitation Research TrainingT32HD007539 · NICHD · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI OTTENBACHER, KENNETH J. · 2001 to 2011
$1.1M
NCATS NIH HHS UL1 TR000071NCRR NIH HHS 1UL1RR029873-01NIAMS NIH HHS AR049877NIAMS NIH HHS R01 AR049877NIA NIH HHS P30 AG024832NICHD NIH HHS T32-HD07539
6 · The paper itself

Abstract

Blood flow restriction (BFR) to contracting skeletal muscle during low-intensity resistance exercise training increases muscle strength and size in humans. However, the mechanism(s) underlying these effects are largely unknown. We have previously shown that mammalian target of rapamycin complex 1 (mTORC1) signaling and muscle protein synthesis (MPS) are stimulated following an acute bout of BFR exercise. The purpose of this study was to test the hypothesis that reactive hyperemia is the mechanism responsible for stimulating mTORC1 signaling and MPS following BFR exercise. Six young men (24 ± 2 yr) were used in a randomized crossover study consisting of two exercise trials: low-intensity resistance exercise with BFR (BFR trial) and low-intensity resistance exercise with sodium nitroprusside (SNP), a pharmacological vasodilator infusion into the femoral artery immediately after exercise to simulate the reactive hyperemia response after BFR exercise (SNP trial). Postexercise mixed-muscle fractional synthetic rate from the vastus lateralis increased by 49% in the BFR trial (P < 0.05) with no change in the SNP trial (P > 0.05). BFR exercise increased the phosphorylation of mTOR, S6 kinase 1, ribosomal protein S6, ERK1/2, and Mnk1-interacting kinase 1 (P < 0.05) with no changes in mTORC1 signaling in the SNP trial (P > 0.05). We conclude that reactive hyperemia is not a primary mechanism for BFR exercise-induced mTORC1 signaling and MPS. Further research is necessary to elucidate the cellular mechanism(s) responsible for the increase in mTOR signaling, MPS, and hypertrophy following acute and chronic BFR exercise.

Indexed as

Muscle ContractionResistance TrainingAdultAnalysis of VarianceBiomarkersBlood GlucoseBlood PressureCross-Over StudiesFemoral ArteryGene Expression RegulationHeart RateHumansHyperemiaInfusions, Intra-ArterialIntracellular Signaling Peptides and ProteinsLactic AcidBiomarkersBlood GlucoseIntracellular Signaling Peptides and ProteinsLactic AcidMAPK1 protein, humanMechanistic Target of Rapamycin Complex 1Mitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3MKNK1 protein, humanMTOR protein, humanMultiprotein ComplexesMuscle ProteinsNitroprussidePhenylalanineProteinsProtein Serine-Threonine KinasesRibosomal Protein S6ribosomal protein S6 kinase, 70kD, polypeptide 1Ribosomal Protein S6 Kinases, 70-kDaTOR Serine-Threonine KinasesUbiquitin-Protein LigasesVasodilator Agents

Identifiers

PMID22362401
PMCPMC3362234
OpenAlexW2075413654

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.